Cardiovascular Systems CSII releases its next round of earnings this Tuesday, August 04. Here's Benzinga's essential guide to Cardiovascular Systems's Q4 earnings report.
Earnings and Revenue
Cardiovascular Systems's EPS will be near $-0.46 on sales of $38.31 million, according to Wall Street analysts.Cardiovascular Systems earnings in the same period a year ago was $0.040 per share. Quarterly sales came in at $68.23 million. Sales would be down 41.78% on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q3 2020 | Q2 2020 | Q1 2019 | Q4 2019 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.01 | -0.08 | 0.04 |
| EPS Actual | -0.08 | -0.10 | -0.17 | 0.04 |
| Revenue Estimate | 65.80 M | 68.02 M | 63.87 M | 66.14 M |
| Revenue Actual | 61.17 M | 68.33 M | 64.49 M | 68.23 M |
Stock Performance
Over the last 52-week period, shares are down 29.5%. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Cardiovascular Systems is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestors.csi360.com%2Fevents-and-presentations%2Fevents-calendar%2Fdefault.aspx&eventid=2405887&sessionid=1&key=2CE0A793E04A445B557FF6C9F10CECB5®Tag=&sourcepage=register
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
